Apimeds Pharmaceuticals US Inc. Company Profile
NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.05-0.08 (-1.12%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 7.05 +1.10%
Apimeds Pharmaceuticals US at a glance
Apimeds Pharmaceuticals US Inc. (NYSE: APUS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2025. At a market capitalization of $10.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001894525, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Apimeds Pharmaceuticals US Inc.
- Ticker
- NYSE: APUS
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2025
- Market cap
- $10.64M
- SEC CIK
- 0001894525
Companies similar to Apimeds Pharmaceuticals US
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TOVXTheriva Biologics Inc. | 0.234 | +5.41% | $10.74M | vs APUS |
| ADILAdial Pharmaceuticals Inc | 3.99 | +0.25% | $10.48M | vs APUS |
| VTGNVistagen Therapeutics Inc. | 0.2471 | -1.40% | $10.97M | vs APUS |
| BLRXBioLineRx Ltd. ADR | 2.21 | -3.80% | $10.98M | vs APUS |
| CALCCalciMedica Inc. | 1.48 | 0.00% | $10.11M | vs APUS |
| GTBPGT Biopharma Inc. | 6.20 | -2.67% | $11.19M | vs APUS |
| KPRXKiora Pharmaceuticals Inc. | 2.53 | +1.20% | $11.19M | vs APUS |
| CMMBChemomab Therapeutics Ltd. ADR | 1.37 | -2.14% | $10.04M | vs APUS |